Stock CGY CALIAN GROUP LTD.
Add to a list
To use this feature you must be a member
Log inSign up

News Calian Group Ltd.

Equities

CGY

CA12989J1084

Market Closed - Toronto S.E.
Other stock markets
 04:00:00 2024-04-17 pm EDT 		5-day change 1st Jan Change
55.49 CAD +0.07% Intraday chart for Calian Group Ltd. -0.72% -3.14%
Mar. 27 Calian Group Brief: Appointing Valerie Travain-Milone as President, Advanced Technologies (AT) MT
Mar. 27 Calian Announces the Appointment of Valérie Travain-Milone as President, Advanced Technologies CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Calian Group Brief: Appointing Valerie Travain-Milone as President, Advanced Technologies (AT)
MT
Calian Announces the Appointment of New President of Advanced Technologies
GL
Calian Announces the Appointment of Valérie Travain-Milone as President, Advanced Technologies
CI
Correction: -- Calian Group Brief: Says to Deliver Spectrum Interference Simulation Technology for the Canadian Space Agency
MT
Calian Group Says to Deliver Spectrum Interference Simulation Technology for the Canadian Space Agency
MT
Calian Group and MDA Brief: Says to Deliver Spectrum Interference Simulation Technology for the Canadian Space Agency
MT
Calian to Deliver Spectrum Interference Simulation Technology for the Canadian Space Agency
GL
Calian Group Ltd. to Deliver Spectrum Interference Simulation Technology for the Canadian Space Agency
CI
Calian : Named to CRN’s 2024 Tech Elite 250 List
PU
Calian : to Support NATO SHAPE in Development and Execution of Military Training Program
PU
North American Morning Briefing : Stock Futures Rise Ahead of Powell's Testimony
DJ
Calian Group and MDA Brief: Calian Says "Strengthens Nuclear Capability" with Acquisition of MDA Ltd. Nuclear Assets
MT
Calian Strengthens Nuclear Capability with Acquisition of MDA Ltd. Nuclear Assets
GL
Calian Group Ltd. acquired Assets And Nuclear Services of MDA Ltd.
CI
Ex-dividend day
FA
Calian Group Says Won Contract to Support Clinical Trial for ZYUS Life Sciences' Lead Drug Product Candidate
MT
Calian Group Brief: Says Won Contract to Support Clinical Trial for ZYUS Life Sciences' Lead Drug Product Candidate
MT
Calian Wins Contract to Support Clinical Trial for ZYUS Life Sciences’ Lead Drug Product Candidate
GL
Calian Group Ltd. Wins Contract to Support Clinical Trial for Zyus Life Sciences? Lead Drug Product Candidate
CI
Calian Reports on the Election of Directors Voting Results
GL
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CGY Stock
  4. News Calian Group Ltd.